A large study of UK health records shows patients receiving systemic glucocorticoids during short hospital stays appeared twice as likely to develop new onset diabetes than those who did not.
People who received systemic glucocorticoids during short hospital stays were more than twice as likely to develop new onset diabetes than those who didn't, reported the authors of a large study that analyzed more than a decade's worth of patient records.
They looked for patients who didn't have a diabetes diagnosis at the time of admission and who were not taking a steroid. Their research was presented this month at the 2024 annual meeting of the The median length of stay was 3 days for the group of patients who took steroids, compared with 1 day in those who did not. Further analysis showed that, when age and sex were factored in, patients receiving systemic glucocorticoids were more than twice as likely to develop diabetes as those not receiving the treatment, Golubic said.
"This gives them a very good estimate of how much more likely people treated with systemic glucocorticoids are to develop new-onset diabetes," Golubic said.
Glucocorticosteroids Glucocorticoid Therapy Glucocorticoid Hospitals UK Site Content United Kingdom Site Content United Kingdom UK
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bizarre treatment may be better for dry eyes than eye drops: studyMore than 360 million people around the world suffer from chronically red, scratchy or irritated eyes, a condition that can worsen with stress.
Read more »
6 Reasons Why Recession Woes May Fall Short AgainMarket Overview Analysis by Ed Yardeni covering: Crude Oil WTI Futures, United States 10-Year. Read Ed Yardeni's latest article on Investing.com
Read more »
This Buzzy New Scalp Care Treatment May Sell Out—and We Scored a DiscountThe Act + Acre Daily Hydro Scalp Serum is a new launch from the scalp-focused hair care brand. It moisturizes dry, itchy scalps for long term benefits like hair growth, and InStyle readers can buy it for 15 percent off with an exclusive code.
Read more »
Nonhormonal Treatment May Ease Menopausal SymptomsA selective antagonist of neurokinin 1 and 3 receptors showed promise in reducing the frequency and severity of vasomotor symptoms.
Read more »
Stocks could hit a record this week, but the move may be short livedThe broad market S&P 500 index entered the week less than 1% below a record last reached in July.
Read more »
DXY: May pullback below 99.58 short termFed cut expectations sent the DXY Index to 100.72 last Friday, near December’s 100.62 low, but was still above the 99.58 low in July 2023, DBS Senior FX Strategist Philip Wee notes.
Read more »